Evidence map›Paper›PMID 21252966›Full record

ReviewJournal of perinatology : official journal of the California Perinatal Association2011

Vitamin D supplementation during pregnancy: safety considerations in the design and interpretation of clinical trials.

D E Roth

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of perinatology : official journal of the California Perinatal Association, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02920593 (A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy), which is not on this map. Cited by 24 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 6 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02920593 phase4unknown statusnot on this mapstarted 2016, after this paper: background citation

A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy

TypeinterventionalSponsorStony Brook UniversityRan2016 to 2019Enrolled412ConditionsGestational Hypertension, Toxemia, Superimposed Preeclampsia, EclampsiaArmsVitamin D3
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 6 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Vitamin D supplementation for women during pregnancy.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Vitamin D supplementation for women during pregnancy.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Vitamin D in pregnancy: current concepts.Current opinion in obstetrics & gynecology · 2012
    Pooled it
  6. Vitamin D supplementation for women during pregnancy.The Cochrane database of systematic reviews · 2012
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia.American journal of physiology. Regulatory, integrative and comparative physiology · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

D E RothDivision of Pediatric Medicine, The Hospital for Sick Children, Toronto, ON, Canada. daniel.roth@sickkids.ca
Hospital for Sick Children · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Maternal-child health benefits of optimizing vitamin D status during pregnancy may include a reduced risk of pre-eclampsia, improved fetal growth and beneficial effects on infant immune function. These hypotheses require evaluation by randomized controlled antenatal vitamin D supplementation trials using doses that are high enough to elevate serum 25-hydroxyvitamin D concentrations into the range believed to be associated with improved health outcomes. Such doses may be considerably higher than the current recommended dietary allowance (600 IU day(-1)) or standard prenatal supplement dose (400 IU day(-1)), and may even be higher than the tolerable upper intake level (4000 IU day(-1)) advised by the Institute of Medicine (2010). A critical review of the published literature yielded limited data regarding the safety of antenatal vitamin D regimens. There have been no published reports of the teratogenic effects of vitamin D on humans. Some animal studies have suggested the potential for dose-dependent fetal toxicities (for example, growth impairment, skeletal malformations and cardiovascular anomalies), but the relevance of these observations to humans is unknown. Antenatal vitamin D supplementation trials should incorporate a range of methods for objectively establishing maternal and fetal safety, and aim to identify the lowest doses of vitamin D required to achieve target outcomes.

Indexed as

Dietary SupplementsMaternal WelfareAnimalsDose-Response Relationship, DrugDrug Administration ScheduleFemaleHumansMaximum Tolerated DosePregnancyPregnancy, AnimalPregnancy ComplicationsRandomized Controlled Trials as TopicRisk AssessmentSafety ManagementTreatment OutcomeVitamin DVitamin D

Identifiers

PMID21252966
OpenAlexW2006474934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.